BARCLAYS PLC - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 98 filers reported holding STOKE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$33
-79.0%
8,440
-43.1%
0.00%
Q2 2023$157
-17.4%
14,829
-35.1%
0.00%
Q1 2023$190
+11.8%
22,860
+23.9%
0.00%
Q4 2022$170
-99.9%
18,443
+74.6%
0.00%
Q3 2022$135,000
+3.1%
10,563
+6.5%
0.00%
Q2 2022$131,000
+33.7%
9,921
+111.8%
0.00%
Q1 2022$98,000
-91.2%
4,685
-89.9%
0.00%
Q4 2021$1,112,000
+377.3%
46,338
+405.4%
0.00%
Q3 2021$233,000
-37.0%
9,169
-16.7%
0.00%
Q2 2021$370,000
-46.1%
11,013
-37.6%
0.00%
Q1 2021$686,000
+115.7%
17,647
+243.8%
0.00%
Q4 2020$318,000
+38.9%
5,133
-24.7%
0.00%
Q3 2020$229,000
-4.2%
6,815
-31.7%
0.00%
Q2 2020$239,000
+68.3%
9,981
+61.0%
0.00%
Q1 2020$142,000
-48.9%
6,198
-37.0%
0.00%
Q4 2019$278,000
+115.5%
9,836
+63.9%
0.00%
Q3 2019$129,000
+377.8%
6,001
+556.6%
0.00%
Q2 2019$27,0009140.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 296,822$7,551,0001.86%
RTW INVESTMENTS, LP 3,644,248$92,710,0001.40%
Cormorant Asset Management, LP 1,278,276$32,519,0001.32%
Redmile Group, LLC 2,381,958$60,597,0001.06%
HighVista Strategies LLC 47,594$1,211,0000.80%
Birchview Capital, LP 15,000$382,0000.26%
GILDER GAGNON HOWE & CO LLC 1,123,355$28,578,0000.15%
Artal Group S.A. 250,000$6,360,0000.14%
Tekla Capital Management LLC 99,263$2,525,0000.08%
Casdin Capital, LLC 120,000$3,053,0000.08%
View complete list of STOKE THERAPEUTICS INC shareholders